TRAVERE THERAPEUTICS, INC. Derivative Liability
TRAVERE THERAPEUTICS, INC. (TVTX) had Derivative Liability of $18.48 million as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2015-07-09
- 2014-09-30: Derivative Liability $18.48M.
- 2014-06-30: Derivative Liability $24.84M.
- 2014-03-31: Derivative Liability $69.35M.
- 2013-12-31: Derivative Liability $25.04M.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2014-09-30 | $18.48M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $24.84M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $69.35M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $25.04M 10-K/A · filed 2015-07-09 | |
| 2013-09-30 | $23.85M 10-Q/A · filed 2015-07-09 | $22.23M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $6.90M 10-Q · filed 2013-09-16 | |
| 2013-03-31 | $6.96M 10-Q/A · filed 2013-09-16 | |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |